About AETHER BIOMEDICAL PRIVATE LIMITED
AETHER BIOMEDICAL PRIVATE LIMITED is a Private Limited Company and was incorporated on Jul 18, 2017 in India. It is registered at Registrar of Companies, ROC Delhi. Its registered address is SHOP A-2, FIRST FLOOR BASISHT COMPLEX, KHANPUR, DELHI, Delhi, India, 110062. Its corporate identification number is (CIN) U33309DL2017PTC320799 and its current status is Active. Its industry classification as per MCA is manufacture Of Watches And Clocks.
AETHER BIOMEDICAL PRIVATE LIMITED's last Annual General Meeting (AGM) was held on Sep 30, 2024 as per records from Ministry of Corporate Affairs (MCA). AETHER BIOMEDICAL PRIVATE LIMITED's authorised share capital is ₹2L and its paid up capital is ₹1.12L. The current board of directors of AETHER BIOMEDICAL PRIVATE LIMITED comprises Nisha ., Dhruv Agrawal and 1 more.
AETHER BIOMEDICAL PRIVATE LIMITED generated less than ₹10 Cr in revenue for the financial year ending on Mar 31, 2022.
Contact Details for AETHER BIOMEDICAL PRIVATE LIMITED
- *****@gmail.com
- Registered Address
- SHOP A-2, FIRST FLOOR BASISHT COMPLEX, KHANPUR, DELHI, Delhi, India, 110062
Brands associated with AETHER BIOMEDICAL PRIVATE LIMITED
Name | Short Description | Founded Year | Location | Current Stage |
|---|---|---|---|---|
Developer of a bionic limb for performing multiple tasks | 2016 | Series A |
Principal Business Activity of AETHER BIOMEDICAL PRIVATE LIMITED
Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
Q | Human health and social work activities | 86 | Human health activities | bfm |
Auditor Details of AETHER BIOMEDICAL PRIVATE LIMITED
Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
Krishna Neeraj and Associates | aepjirq | vqnztgh | whb{cei |
Documents of AETHER BIOMEDICAL PRIVATE LIMITED
Financials of AETHER BIOMEDICAL PRIVATE LIMITEDFY 25 Available
Financial Statement Summary
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Income Statement | |||||
Revenue | 5855 | 8903 | 3890 | 9084 | 6453 |
EBITDA | 8497 | 4663 | 9926 | 7539 | 3213 |
Balance Sheet | |||||
Assets | 8249 | 5356 | 6905 | 6533 | 5558 |
Liabilities | 8114 | 4530 | 4266 | 9489 | 5303 |
Equities | 5383 | 5859 | 2768 | 6639 | 6463 |
Ratios
Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
Profitability Ratios | |||||
EBITDA Margin | 2344 | 2328 | 6601 | 5331 | 5794 |
Efficiency Ratios | |||||
Asset Turnover | 1836 | 6234 | 4588 | 6948 | 7515 |
Liquidity Ratios | |||||
Current Ratio | 9724 | 8675 | 7473 | 3797 | 5715 |
Quick Ratio | 3005 | 2161 | 7074 | 5740 | 1359 |
Growth Ratios | |||||
Revenue Growth Rate (CAGR) | 4911 | 8996 | 9597 | 1920 | 2311 |
Detailed Financials (Income Statement, Balance Sheet, Cashflow Statement)
MSME Payment Delays by AETHER BIOMEDICAL PRIVATE LIMITED
Credit Ratings of AETHER BIOMEDICAL PRIVATE LIMITED
GSTIN Details of AETHER BIOMEDICAL PRIVATE LIMITED
Board of Directors and Signatories of AETHER BIOMEDICAL PRIVATE LIMITED
Board of Directors of AETHER BIOMEDICAL PRIVATE LIMITED
Name | Designation | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jul 18, 2017 | 8 Years 8 Months | |
Director | Current | Jul 18, 2017 | 8 Years 8 Months | |
Director | Current | Jul 18, 2017 | 8 Years 8 Months |
Signatories of AETHER BIOMEDICAL PRIVATE LIMITED
Name | Designation(s) | Status | Appointment Date | Duration |
|---|---|---|---|---|
Director | Current | Jul 18, 2017 | 8 Years 8 Months | |
Director | Current | Jul 18, 2017 | 8 Years 8 Months | |
Director | Current | Jul 18, 2017 | 8 Years 8 Months |
Legal Cases involving AETHER BIOMEDICAL PRIVATE LIMITED
Trademarks of AETHER BIOMEDICAL PRIVATE LIMITED
Patents of AETHER BIOMEDICAL PRIVATE LIMITED
Competitors & Alternates of AETHER BIOMEDICAL PRIVATE LIMITED
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of prostheses and orthoses devices for orthopedic supports | - | 60/100 | ||
2nd | CIONIC 2018, Scotts Valley (United States), Series A | Provider of bionic clothing for mobility impairment | $32.3M | 59/100 | |
3rd | Developer of AI-powered exoskeletons and gait analysis tools for mobility recovery. This company offers a two-step solution for outpatient clinics. The first step involves REEV SENSE, a gait analysis system using wearable sensors to assess patient mobility. The second step utilizes DREEVEN, a smart motorized knee brace that provides robotic assistance, personalized based on the REEV SENSE data. The system aims to improve patient outcomes and daily mobility for individuals with neurological gait disorders. The company's technology helps healthcare professionals efficiently evaluate gait patterns and provide targeted support for rehabilitation. | $12.4M | 55/100 | ||
4th | Epica International 2014, San Clemente (United States), Series B | Provider of robotic CT platforms for healthcare and industrial applications | $25.7M | 54/100 | |
5th | Aether Biomedical 2016, Poznan (Poland), Series A | Developer of a bionic limb for performing multiple tasks | $10.3M | 50/100 | |
6th | Axiles Bionics 2018, Brussels (Belgium), Series A | Provider of ankle-foot prosthesis for specially abled people | $6.91M | 50/100 | |
7th | Open Bionics 2014, Bristol (United Kingdom), Series A | Manufactures robotic prosthetic hand | $6.98M | 49/100 | |
8th | Makers Hive Innovations 2018, Hyderabad (India), Series A | Manufacturer of affordable, customizable bionic hands and associated mobile application | $9M | 48/100 | |
9th | Developer of orthopedic bracing and support products | - | 46/100 | ||
10th | Provider of smart prosthetic technology for orthopedic rehabilitation | $7.45M | 46/100 |